AbrahamSebastianKanateMD

Oncology • Scottsdale, AZ

Hematologic Oncology

Associate Professor, Medicine, West Virginia University SOM

Join to view full profile

Dr. Kanate is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kanate's full profile

Already have an account?

Office
10460 N 92nd St Ste 300
Scottsdale, AZ 85258
Phone+1 480-323-1573

Education & Training

West Virginia UniversityFellowship, Hematology and Medical Oncology, 2008 - 2011
West Virginia UniversityResidency, Internal Medicine, 2005 - 2008
St. John's Medical CollegeClass of 2003

Certifications & Licensure

CA State Medical License 2011 - Present
AZ State Medical License 2021 - 2027
WV State Medical License 2008 - 2022
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Once Daily Targeted Intravenous (IV) Busulfex as Part of Reduced-toxicity Conditioning for Patients With Refractory Lymphomas Undergoing Allogeneic Transplantation Start of enrollment: 2010 Oct 12
Completed
Phase 2
Treatment of Severe Mucositis Pain With Oral Ketamine Mouthwash Start of enrollment: 2012 Feb 01
Completed
Phase 2
Atorvastatin as GVHD Prophylaxis for Allogeneic Hematopoietic Cell Transplantation Start of enrollment: 2014 Jan 20
Completed
Phase 2
Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Start of enrollment: 2014 Feb 20
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

1 citations
Clinical Practice Recommendations for Hematopoietic Cell Transplantation and Cellular Therapies in Follicular Lymphoma: A Collaborative Effort on Behalf of the America...
Madiha Iqbal, Ambuj Kumar, Peter Dreger, Julio Chavez, Craig S Sauter
Transplantation and Cellular Therapy. 2024-09-01
24 citations
Updated Indications for Immune Effector Cell Therapy: 2023 Guidelines from the American Society for Transplantation and Cellular Therapy.
Abraham S Kanate, Navneet Majhail, Zachariah DeFilipp, Binod Dhakal, Bhagirathbhai Dholaria
Transplantation and Cellular Therapy. 2023-10-01
10 citations
Haploidentical Versus Matched Unrelated Donor Transplants Using Post-Transplantation Cyclophosphamide for Lymphomas.
Alberto Mussetti, Abraham S Kanate, Tao Wang, Meilun He, Mehdi Hamadani
Transplantation and Cellular Therapy. 2023-03-01

Lectures

Health-Related Quality of Life Among Patients with Relapsed or Refractory Multiple Myeloma Who Received Pomalidomide, Bortezomib, and Low-Dose Dexamethasone Versus Bor...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

Glendale Radiation Oncology Center Adds DoctorAugust 13th, 2021